Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Riociguat for treatment of pulmonary hypertension in COPD – a translational study

Alexandra Pichl, Natascha Sommer, Mariola Bednorz, Michael Seimetz, Stefan Hadzic, Stefan Kuhnert, Simone Kraut, Elsa T. Roxlau, Baktybek Kojonazarov, Jochen Wilhelm, Marija Gredic, Henning Gall, Khodr Tello, Manuel J. Richter, Oleg Pak, Aleksandar Petrovic, Matthias Hecker, Ralph T. Schermuly, Friedrich Grimminger, Werner Seeger, Hossein A. Ghofrani, Norbert Weissmann
European Respiratory Journal 2019; DOI: 10.1183/13993003.02445-2018
Alexandra Pichl
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natascha Sommer
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariola Bednorz
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Seimetz
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Hadzic
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Kuhnert
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Kraut
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elsa T. Roxlau
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baktybek Kojonazarov
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jochen Wilhelm
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marija Gredic
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henning Gall
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Henning Gall
Khodr Tello
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel J. Richter
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oleg Pak
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aleksandar Petrovic
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Hecker
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph T. Schermuly
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Friedrich Grimminger
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Werner Seeger
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
2Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hossein A. Ghofrani
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norbert Weissmann
1Excellence Cluster Cardiopulmonary System, University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: norbert.weissmann@innere.med.uni-giessen.de
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Chronic obstructive pulmonary disease (COPD) which comprises the phenotypes of chronic bronchitis and emphysema is often associated with pulmonary hypertension (PH). However, currently no approved therapy exists for PH-COPD. Signalling of the nitric oxide/cyclic guanoside monophosphate (NO-cGMP) axis plays an important role in PH and COPD.

We investigated the treatment effect of riociguat, which promotes the NO-cGMP pathway, in the mouse model of smoke-induced PH and emphysema in a curative approach and retrospectively analysed the effect of riociguat treatment on PH in single patients with PH-COPD.

In mice with established PH and emphysema (after 8 months of cigarette smoke exposure) riociguat treatment for another 3 months fully reversed PH. Moreover, histological hallmarks of emphysema were decreased. Microarray analysis revealed involvement of different signalling pathways, e.g. related to matrix metalloproteinases (MMPs). MMP activity was decreased in vivoby riociguat. In PH-COPD patients treated with riociguat (n=7) the pulmonary vascular resistance, airway resistance and circulating MMP levels decreased, while oxygenation at rest was not significantly changed.

Conclusions: Riociguat may be beneficial for treatment of PH-COPD. Further long-term prospective studies are necessary to investigate the tolerability, efficacy on functional parameters and the effect specifically on pulmonary emphysema in COPD patients.

Footnotes

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of interest: Dr. Pichl has nothing to disclose.

Conflict of interest: Dr. Sommer has nothing to disclose.

Conflict of interest: Dr. Bednorz has nothing to disclose.

Conflict of interest: Dr. Seimetz has nothing to disclose.

Conflict of interest: Mr. Hadzic has nothing to disclose.

Conflict of interest: Dr. Kuhnert reports non-financial support from TEVA, personal fees from Chiesi, personal fees and non-financial support from GSK, personal fees and non-financial support from Novartis, personal fees from Berlin Chemie MENARINI, non-financial support from BAYER, non-financial support from ASTELLAS, personal fees from AstraZeneca, outside the submitted work; .

Conflict of interest: Dr. Kraut has nothing to disclose.

Conflict of interest: Dr. Roxlau has nothing to disclose.

Conflict of interest: Dr. Kojonazarov has nothing to disclose.

Conflict of interest: Dr. Wilhelm has nothing to disclose.

Conflict of interest: MSc Gredic has nothing to disclose.

Conflict of interest: Dr. Gall reports grants and personal fees from Actelion, AstraZeneca, Bayer, BMS, GlaxoSmithKline, Janssen Cilag, Lilly, Merck Sharp Dohme, Novartis, Pfizer, and UnitedTherapeutics/OMT, outside the submitted work.

Conflict of interest: Dr. Tello has nothing to disclose.

Conflict of interest: Dr. Richter reports grants from United Therapeutics, grants and personal fees from Bayer, personal fees from Actelion, personal fees from Mundipharma, personal fees from Roche, personal fees from OMT, outside the submitted work; .

Conflict of interest: Dr. Pak has nothing to disclose.

Conflict of interest: Dr. Petrovic has nothing to disclose.

Conflict of interest: Dr. Hecker has nothing to disclose.

Conflict of interest: Dr. Schermuly has nothing to disclose.

Conflict of interest: Friedrich Grimminger

Conflict of interest: Dr. Seeger has received honoraria for consultant activities from Bayer, United Therapeutics, and Liquidia , outside the submitted work.

Conflict of interest: Dr. Ghofrani reports personal fees from Actelion, Bayer, GSK, Novartis, Pfizer, personal fees from Actelion, Bayer, GSK, MSD Merck Sharpe & Dohme, Novartis, Pfizer, personal fees from Actelion, Bayer, GSK, Novartis, Pfizer, personal fees from Actelion, Bayer, GSK, MSD Merck Sharpe & Dohme, Novartis, Pfizer, grants from Deutsche Forschungsgemeinschaft (DFG), outside the submitted work.

Conflict of interest: Dr. Weissmann has nothing to disclose.

This is a PDF-only article. Please click on the PDF link above to read it.

  • Copyright ©ERS 2019
PreviousNext
Back to top
View this article with LENS
Vol 62 Issue 5 Table of Contents
European Respiratory Journal: 62 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Riociguat for treatment of pulmonary hypertension in COPD – a translational study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Riociguat for treatment of pulmonary hypertension in COPD – a translational study
Alexandra Pichl, Natascha Sommer, Mariola Bednorz, Michael Seimetz, Stefan Hadzic, Stefan Kuhnert, Simone Kraut, Elsa T. Roxlau, Baktybek Kojonazarov, Jochen Wilhelm, Marija Gredic, Henning Gall, Khodr Tello, Manuel J. Richter, Oleg Pak, Aleksandar Petrovic, Matthias Hecker, Ralph T. Schermuly, Friedrich Grimminger, Werner Seeger, Hossein A. Ghofrani, Norbert Weissmann
European Respiratory Journal Jan 2019, 1802445; DOI: 10.1183/13993003.02445-2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Riociguat for treatment of pulmonary hypertension in COPD – a translational study
Alexandra Pichl, Natascha Sommer, Mariola Bednorz, Michael Seimetz, Stefan Hadzic, Stefan Kuhnert, Simone Kraut, Elsa T. Roxlau, Baktybek Kojonazarov, Jochen Wilhelm, Marija Gredic, Henning Gall, Khodr Tello, Manuel J. Richter, Oleg Pak, Aleksandar Petrovic, Matthias Hecker, Ralph T. Schermuly, Friedrich Grimminger, Werner Seeger, Hossein A. Ghofrani, Norbert Weissmann
European Respiratory Journal Jan 2019, 1802445; DOI: 10.1183/13993003.02445-2018
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Pulmonary vascular disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Spirometer controlled cine-MRI and TBM in paediatric patients
  • Prior CV disease and mortality COPD pneumonia patients
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society